Skip to main
DAVA

DAVA Stock Forecast & Price Target

DAVA Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 0%
Hold 40%
Sell 20%
Strong Sell 0%

Bulls say

Endava is facing challenges in meeting analyst expectations, with lower than expected guidance and a decline in key operating metrics such as headcount and revenue. This is likely due to weakened technology spending in their key industries, specifically the payments and insurance sectors. However, the company's focus on AI and reskilling show potential for future growth.

Bears say

Endava is currently facing numerous headwinds, including declining revenues across all verticals and geographies, decreasing headcount, and lower margins. Its high reliance on the UK and Europe for revenue also exposes it to political and economic risks, such as Brexit. Additionally, increased competition for talent could impact its ability to hire and retain staff, hindering its growth potential. Furthermore, the uncertainty around the timing of a return to revenue growth and normalized margins, along with the lack of timeline on revenue inflection and return to historical margin profiles, makes it difficult to have a positive outlook on the stock.

DAVA has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 0% recommend Buy, 40% suggest Holding, 20% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Endava plc - ADR and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Endava plc - ADR (DAVA) Forecast

Analysts have given DAVA a Buy based on their latest research and market trends.

According to 5 analysts, DAVA has a Buy consensus rating as of Aug 2, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $6.10, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $6.10, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Endava plc - ADR (DAVA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.